6.78
price down icon7.50%   -0.55
after-market Dopo l'orario di chiusura: 6.78
loading
Precedente Chiudi:
$7.33
Aprire:
$7.08
Volume 24 ore:
1.03M
Relative Volume:
2.32
Capitalizzazione di mercato:
$582.74M
Reddito:
$14.02M
Utile/perdita netta:
$-84.03M
Rapporto P/E:
-4.6122
EPS:
-1.47
Flusso di cassa netto:
$-125.54M
1 W Prestazione:
-11.83%
1M Prestazione:
-4.91%
6M Prestazione:
+62.59%
1 anno Prestazione:
+11.70%
Intervallo 1D:
Value
$6.63
$7.17
Intervallo di 1 settimana:
Value
$6.63
$7.95
Portata 52W:
Value
$3.85
$8.75

Meiragtx Holdings Plc Stock (MGTX) Company Profile

Name
Nome
Meiragtx Holdings Plc
Name
Telefono
646-860-7985
Name
Indirizzo
450 EAST 29TH STREET, NEW YORK, NY
Name
Dipendente
0
Name
Cinguettio
@MeiraGTx
Name
Prossima data di guadagno
2025-03-12
Name
Ultimi documenti SEC
Name
MGTX's Discussions on Twitter

Confronta MGTX con altri titoli

Azioni Prezzo Cap. di mercato Reddito Reddito netto Flusso di cassa EPS
Biotechnology icon
MGTX
Meiragtx Holdings Plc
6.78 582.74M 14.02M -84.03M -125.54M -1.47
Biotechnology icon
VRTX
Vertex Pharmaceuticals Inc
484.82 131.41B 11.02B -535.60M -978.00M -2.20
Biotechnology icon
REGN
Regeneron Pharmaceuticals Inc
634.23 72.26B 14.20B 4.41B 3.54B 38.28
Biotechnology icon
ARGX
Argen X Se Adr
591.87 36.10B 2.19B 833.04M -1.28B 12.71
Biotechnology icon
ALNY
Alnylam Pharmaceuticals Inc
270.02 35.03B 2.25B -278.16M -42.59M -2.17
Biotechnology icon
ONC
Beigene Ltd Adr
272.17 28.24B 3.81B -644.79M -669.77M -6.24

Meiragtx Holdings Plc Stock (MGTX) Upgrades & Downgrades

Data Azione Analista Modifica della valutazione
2024-07-31 Ripresa Chardan Capital Markets Buy
2020-10-23 Iniziato RBC Capital Mkts Outperform
2020-09-15 Ripresa BofA Securities Buy
2019-09-03 Iniziato Piper Jaffray Overweight
2019-02-27 Reiterato Chardan Capital Markets Buy
2018-07-03 Iniziato Barclays Overweight
2018-07-03 Iniziato BofA/Merrill Buy
Mostra tutto

Meiragtx Holdings Plc Borsa (MGTX) Ultime notizie

pulisher
Mar 30, 2025

Chardan Capital Forecasts MeiraGTx FY2026 Earnings - MarketBeat

Mar 30, 2025
pulisher
Mar 28, 2025

Chardan Capital Comments on MeiraGTx FY2026 Earnings - Defense World

Mar 28, 2025
pulisher
Mar 27, 2025

MeiraGTx Holdings plc (NASDAQ:MGTX) Stock Position Increased by Bank of New York Mellon Corp - Defense World

Mar 27, 2025
pulisher
Mar 27, 2025

Chardan Capital Forecasts MeiraGTx FY2025 Earnings - Defense World

Mar 27, 2025
pulisher
Mar 25, 2025

MeiraGTx Holdings: Gaining Regulatory Focus (NASDAQ:MGTX) - Seeking Alpha

Mar 25, 2025
pulisher
Mar 24, 2025

MeiraGTx Holdings plc (NASDAQ:MGTX) Is Expected To Breakeven In The Near Future - Yahoo Finance

Mar 24, 2025
pulisher
Mar 22, 2025

Reviewing MeiraGTx (NASDAQ:MGTX) and CRISPR Therapeutics (NASDAQ:CRSP) - Defense World

Mar 22, 2025
pulisher
Mar 18, 2025

MeiraGTx (NASDAQ:MGTX) Given New $13.00 Price Target at Royal Bank of Canada - Defense World

Mar 18, 2025
pulisher
Mar 18, 2025

MeiraGTx Holdings (MGTX) Partners with Hologen for $200M AI-Powered Parkinson’s Treatment - Insider Monkey

Mar 18, 2025
pulisher
Mar 17, 2025

RBC Capital raises MeiraGTx stock price target to $13.00 By Investing.com - Investing.com Canada

Mar 17, 2025
pulisher
Mar 17, 2025

RBC Capital raises MeiraGTx stock price target to $13.00 - Investing.com

Mar 17, 2025
pulisher
Mar 17, 2025

RBC Raises Price Target on MeiraGTx Holdings to $13 From $11, Keeps Outperform, Speculative Risk - MarketScreener

Mar 17, 2025
pulisher
Mar 16, 2025

When the Price of (MGTX) Talks, People Listen - news.stocktradersdaily.com

Mar 16, 2025
pulisher
Mar 16, 2025

MeiraGTx (NASDAQ:MGTX) Sees Strong Trading Volume – Here’s Why - Defense World

Mar 16, 2025
pulisher
Mar 14, 2025

Top 10 AI News Updates Taking Wall Street By Storm - Insider Monkey

Mar 14, 2025
pulisher
Mar 14, 2025

Plaudits For MeiraGTx And Its Parkinson’s AI Pact - insights.citeline.com

Mar 14, 2025
pulisher
Mar 14, 2025

US$200M Deal Accelerates Phase 3 Gene Therapy for Parkinsons - Streetwise Reports

Mar 14, 2025
pulisher
Mar 14, 2025

MeiraGTx Holdings plc's (NASDAQ:MGTX) 29% Price Boost Is Out Of Tune With Revenues - Simply Wall St

Mar 14, 2025
pulisher
Mar 13, 2025

MGTX stock touches 52-week high of $7.9 amid market optimism - Investing.com

Mar 13, 2025
pulisher
Mar 13, 2025

MeiraGTx Shares Soar After Joint Venture Deal With Hologen -March 13, 2025 at 03:31 pm EDT - Marketscreener.com

Mar 13, 2025
pulisher
Mar 13, 2025

Top Midday Gainers -March 13, 2025 at 02:24 pm EDT - Marketscreener.com

Mar 13, 2025
pulisher
Mar 13, 2025

MGTX’s price-to-sales ratio: A comparative analysis with its peers - US Post News

Mar 13, 2025
pulisher
Mar 13, 2025

MeiraGTx Holdings plc SEC 10-K Report - TradingView

Mar 13, 2025
pulisher
Mar 13, 2025

MeiraGTx earnings beat by $0.08, revenue topped estimates - Investing.com UK

Mar 13, 2025
pulisher
Mar 13, 2025

MeiraGTx Collaborates With Hologen AI To Expedite Development Of Parkinson's Candidate, Stock Soars - Benzinga India

Mar 13, 2025
pulisher
Mar 13, 2025

MeiraGTx (MGTX) Stock Climbs in Pre-Hour Trading - Stocks Telegraph

Mar 13, 2025
pulisher
Mar 13, 2025

MeiraGTx secures $200 million, forms joint venture for CNS drugs By Investing.com - Investing.com Australia

Mar 13, 2025
pulisher
Mar 13, 2025

MeiraGTx Secures $200 Mln From Hologen For Phase 3 Dvpt. Of AAV-GAD, Establish Neuro-AI JV - Nasdaq

Mar 13, 2025
pulisher
Mar 13, 2025

MeiraGTx Holdings PLC reports results for the quarter ended December 31Earnings Summary - TradingView

Mar 13, 2025
pulisher
Mar 13, 2025

MeiraGTx Holdings Announces Joint Venture with Hologen - TipRanks

Mar 13, 2025
pulisher
Mar 13, 2025

MeiraGTx secures $200 million, forms joint venture for CNS drugs - Investing.com

Mar 13, 2025
pulisher
Mar 13, 2025

MeiraGTx Reports Fourth Quarter and Full Year 2024 Financial and Operational Results and Recent Business Updates - The Manila Times

Mar 13, 2025
pulisher
Mar 13, 2025

MeiraGTx stock surges on Hologen AI deal By Investing.com - Investing.com South Africa

Mar 13, 2025
pulisher
Mar 13, 2025

MeiraGTx stock surges on Hologen AI deal - Investing.com India

Mar 13, 2025
pulisher
Mar 13, 2025

MeiraGTx Enters into a Strategic Collaboration with Hologen AI to Expedite Phase 3 Development of AAV-GAD for Parkinson's Disease and Industrialize MeiraGTx's Proprietary Manufacturing Process - The Manila Times

Mar 13, 2025
pulisher
Mar 13, 2025

MeiraGTx and Hologen Limited Announce $200 Million Collaboration and Formation of Hologen Neuro AI Ltd Joint Venture for Parkinson's Disease Development - Nasdaq

Mar 13, 2025
pulisher
Mar 12, 2025

Piper Sandler maintains Overweight on MeiraGTx stock, $26 target By Investing.com - Investing.com South Africa

Mar 12, 2025
pulisher
Mar 12, 2025

Piper Sandler maintains Overweight on MeiraGTx stock, $26 target - Investing.com India

Mar 12, 2025
pulisher
Mar 10, 2025

MeiraGTx Holdings PLC expected to post a loss of 56 cents a shareEarnings Preview - TradingView

Mar 10, 2025
pulisher
Mar 10, 2025

MeiraGTx Holdings plc (NASDAQ:MGTX) Shares Purchased by Rhumbline Advisers - Defense World

Mar 10, 2025
pulisher
Mar 06, 2025

MeiraGTx (MGTX) Projected to Post Quarterly Earnings on Thursday - Defense World

Mar 06, 2025
pulisher
Mar 05, 2025

(MGTX) Investment Analysis - Stock Traders Daily

Mar 05, 2025
pulisher
Mar 04, 2025

2025 Market Prospects of Adeno-Associated Virus Vectors in Gene Therapy Pipeline: 200 Pipeline Drugs and the Strategic Workings of 180+ Companies - GlobeNewswire Inc.

Mar 04, 2025
pulisher
Feb 27, 2025

MeiraGTx (NASDAQ:MGTX) Receives "Buy" Rating from Chardan Capital - MarketBeat

Feb 27, 2025
pulisher
Feb 25, 2025

MeiraGTx Holdings plc (MGTX) expanding its growth trajectory ahead - SETE News

Feb 25, 2025
pulisher
Feb 25, 2025

MeiraGTx’s (MGTX) Buy Rating Reaffirmed at Chardan Capital - Defense World

Feb 25, 2025
pulisher
Feb 24, 2025

MeiraGTx seeks UK approval after gene therapy restores sight in children born blind - Yahoo Finance

Feb 24, 2025
pulisher
Feb 23, 2025

MeiraGTx (NASDAQ:MGTX) Reaches New 52-Week High – What’s Next? - Defense World

Feb 23, 2025
pulisher
Feb 23, 2025

Long Term Trading Analysis for (MGTX) - news.stocktradersdaily.com

Feb 23, 2025
pulisher
Feb 21, 2025

MeiraGTx rises after publication of positive data from gene therapy trial for eye disorder - Seeking Alpha

Feb 21, 2025
pulisher
Feb 21, 2025

Meiragtx’s gene therapy shows ‘exceptional’ data for blind children - BioWorld Online

Feb 21, 2025

Meiragtx Holdings Plc Azioni (MGTX) Dati Finanziari

Reddito

loading

Reddito netto

loading

Flusso di cassa

loading

EPS

loading
$70.69
price down icon 1.05%
$76.29
price down icon 2.18%
$31.13
price down icon 0.77%
$19.29
price down icon 5.07%
$91.06
price down icon 4.10%
biotechnology ONC
$272.17
price up icon 1.79%
Capitalizzazione:     |  Volume (24 ore):